This e-learning course reviews the topic of radiopharmaceuticals and their use in metastatic castration-resistant prostate cancer.

International experts in the field of GU Oncology and Nuclear Medicine provide an overview of radiopharmaceuticals used in prostate cancer.

In this first episode the discussion covers:

  • Key data related to radiopharmaceuticals.
  • The mechanism of action of such treatments.
  • Practical considerations related to treatment sequencing.
  • General radiation safety.

We highly recommend the e-learning course for Episode 2 of this podcast to continue your learning, which focuses on theranostics with PSMA-targeted radiopharmaceuticals.

This course has been accredited by EACCME®. For every hour of learning completed on COR2ED Checkpoint you will be able to claim 1 ECMEC® if you pass the assessment quiz for each of the courses you take. The expected duration of this course is 30 minutes.

Certification Type: eaccme
Duration Time: 30